Home › Gilead's hepatitis C drugs largely cost-effective in US: study
 

Keywords :   


Gilead's hepatitis C drugs largely cost-effective in US: study

2015-03-17 04:45:41| Biotech - Topix.net

New hepatitis C drugs that shorten treatment times are largely cost-effective despite their hefty U.S. price tags, according to two new analyses. The widespread use of a combination of drugs that include Gilead Sciences Inc's Sovaldi, known generically as sofosbuvir, will nonetheless be a significant cost for the U.S. healthcare system, researchers wrote.

Tags: us study drugs largely

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
12.10Atlantic Tropical Weather Outlook
12.10Eastern North Pacific Tropical Weather Outlook
12.10Remnants of Leslie Graphics
12.10Remnants of Leslie Forecast Discussion Number 41
12.10Remnants of Leslie Wind Speed Probabilities Number 41
12.10Remnants of Leslie Public Advisory Number 41
12.10Summary for Remnants of Leslie (AT3/AL132024)
12.10Remnants of Leslie Forecast Advisory Number 41
More »